- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Lipids, Atherosclerosis, & Thrombosis: A Cardiometabolic Disease Quiz
When is aspirin appropriate in primary ASCVD prevention? Should ezetimibe be added to maximal statin therapy in T2D? This quiz tests your guideline savvy.
According to the American College of Cardiology, an estimated 47 million persons in the US are living with cardiometabolic disorders, placing them at significantly increased risk for type 2 diabetes (T2D) and cardiovascular disease including hypertension, coronary heart disease, and stroke.
Guidelines on prevention of atherosclerotic cardiovascular disease from the American College of Cardiology/American Heart Association, the American Diabetes Association, and the Endocrine Society provide recommendations for reducing the risk of morbidity and mortality associated with this cluster of metabolic dysfunction.
Test your knowledge of guideline-recommended management with Quiz #2 in our series of 4 on cardiometabolic disease.
Roche, Alnylam Advance Zilebesiran Into Phase 3 CV Outcomes Trial for Resistant Hypertension
September 9th 2025Zilebesiran’s twice-yearly dosing and sustained BP reductions could offer a new therapeutic approach for adults with resistant hypertension and high CV risk who are uncontrolled on current SOC regimens.
